Lack of associations between serum leptin, a polymorphism in the gene for the β3-adrenergic receptor and glucose tolerance in the Dutch population

Clinical Endocrinology

Volumn 49, Issue 2, 1998, Pages 229-234

  Janssen, J A M J L ^a,e   Koper, J W ^a   Stolk, R P ^b   Englaro, P ^c   Uitterlinden, A G ^a   Huang, Q ^a   Van Leeuwen, J P T M ^a   Blum, W F ^c,d   Attanasio, A M F ^d   Pols, H A P ^a   Grobbee, D E ^a,b   De Jong, F H ^a   Lamberts, S W J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

^d ELI LILLY AND COMPANY   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN; LEPTIN; TRYPTOPHAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GLUCOSE TOLERANCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POINT MUTATION; POPULATION RESEARCH; PRIORITY JOURNAL;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; PROTEINS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; REGRESSION ANALYSIS;

EID: 15444339759     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00513.x     Document Type: Article

References (27)

1. Anonymous (1985) Diabetes Mellitus, Technical report series 727. World Health Organization, Geneva.
2. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care, 19, 271-272.
3. Blum, W.F., Englaro, P., Hanitsch, S., Juul, A., Hertel, N.T., Müller, J., Skakkebæk, N.E., Heiman, M.L., Birkett, M., Attanasio, A.M., Kiess, W. & Rascher, W. (1997) Plasma leptin levels in children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage and testosterone. Journal of Clinical Endocrinology and Metabolism, 82, 2904-2910.
4. Bodkin, N.L., Nicolson, M., Ortmeyer, H.K. & Hansen, B.C. (1996) Hyperleptinemia: Relationship to adiposity and insulin resistance in the spontaneously obese Rhesus monkey. Hormone and Metabolic Research, 28, 674-678.
5. Campfield, L.A., Smith, F.J. & Bum, P. (1996) The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks. Hormone and Metabolic Research, 28, 619-632.
6. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New England Journal of Medicine, 333, 352-354.
7. 3-adrenergic receptor on weight gain in morbid obesity. International Journal of Obesity, 20, 1062-1066.
8. Considine, R.V., Considine, E.L., Williams, C.J., Nyce, M.R., Magosin, S.A. & Bauer, T.L. (1995) Evidence against either a premature stop codon or the the absence of obese gene mRNA in human obesity. Journal of Clinical Investigation, 95, 2986-2988.
9. 3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. Journal of Clinical Endocrinology and Metabolism, 81, 4422-4427.
10. 3-adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects Cohorts. Journal of Clinical Investigation, 98, 2086-2093.
11. 3-adrenoreceptor: an update. European Journal of Endocrinology, 132, 377-385.
12. 3-adrenoceptor in the control of leptin expression. Hormone and Metabolic Research, 28, 633-637.
13. Hofman, A., Grobbee, D.E., de Jong, P.T.V.M. & de Ouweland, F.A. (1991) Determinants of disease and disability in the elderly: The Rotterdam Study. European Journal of Epidemiology, 7, 403-422.
14. 3-adrenergic receptor gene is associated with obesity and insulin resistance in Japanese subjects. Biochemical and Biophysical Research Communications, 215, 555-560.
15. 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Diabetes, 45, 1358-1363.
16. Maffei, M., Halaas, J., Ravussin, E., Partley, R.E., Lee, G.H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., Kern, P.A. & Friedman, J.M. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine, 1, 1155-1161.
17. 3-adrenoreceptor gene of doubtful significance for obesity and insulin resistance. Lancet, 348, 698-699.
18. Moinat, M., Deng, C., Muzzin, P., Assimacopoulos-Jeannet, F., Seydoux, J., Dulloo, A.G. & Giacobino, J.-P. (1995) Modulation of obese gene expression in rat brown and white adipose tissues. FEBS Letters, 373, 131-134.
19. Muzzin, P., Revelli, J.P., Kuhne, F., Gocayne, J.D., Mccombie, W.R., Venter, J.C., Giacobino, J.-P. & Fraser, C.M. (1991) An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. Journal of Biological Chemistry, 266, 24053-24058.
20. Mykkänen, L., Laakso, M. & Pyörälä, K. (1992) Association of obesity and distribution of obesity with glucose tolerance and cardiovascular risk factors in the elderly. International Journal of Obesity, 16, 695-704.
21. Ott, A., Stolk, R.P., Hofman, A., van Harskamp, F., Grobbee, D.E. & Breteler, M.M.B. (1996) Association of diabetes mellitus and dementia. Diabetologia, 39, 1392-1397.
22. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care, 19, 1034-1035.
23. 3-adrenoreceptor gene variant in obesity and insulin resistance. Lancet, 348, 1584-1585.
24. 3-adrenergic receptor gene. Diabetes, 45, 1115-1120.
25. 3-adrenergic receptor gene. New England Journal of Medicine, 333, 343-347.
26. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. New England Journal of Medicine, 333, 348-351.
27. 3-adrenergic-receplor gene and response to treatment of obesity. Lancet, 346, 1433-1434.